Effect of 5-HT4 receptor agonist on sensorimotor rectosigmoid function in patients with irritable bowel syndrome (IBS)

Effect of 5-HT4 receptor agonist on sensorimotor rectosigmoid function in patients with irritable bowel syndrome (IBS) - IBS-5HT-MOT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1091220040

Enrollment

Registered

2010-06-11

Start date

2005-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome

Interventions

Intervention type:DRUG Name of intervention:Mosapride citrate Dose form / Japanese Medical Device Nomenclature:POWDER Route of administration / Site of application:ORAL Dose per administration:15 mg D

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Individuals who met Rome II diagnostic criteria for IBS

Exclusion criteria

Exclusion criteria: Individuals who had suffered serious physical or psychiatric complications

Design outcomes

Primary

Measure	Time frame
Rectosigmoid motility	—

Secondary

Measure	Time frame
Rectosigmoid perception	—

Countries

Japan

Contacts

Public ContactMotoyori Kanazawa

Tohoku University Graduate School of Medicine

mkanazw@mail.tains.tohoku.ac.jp+81-22-717-7655

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026